In a prior post, I discussed litigation (Martinez v. Kraft Heinz Company, et al.) against 11 manufacturers of ultra-processed foods (UPFs) for causing a 16-year-old to develop Type 2 Diabetes and Fatty Liver Disease.
Psilocybin should be regulated under food law rather than drug law. Doing so would serve public health, individual autonomy, and regulatory coherence.
On July 1, the federal government quietly scaled back its only active surveillance system for foodborne illnesses.
Recently three key areas have attracted special EU attention: sustainability, biodiversity, and food supply and security.
Concerns over ultra-processed foods (UPFs) and their responsibility for rising rates of chronic disease and obesity have been highlighted in the medical literature and in the popular press.
How do we know what is healthy? Given the link between healthy eating patterns and diet-related diseases, consumers need accurate information to make informed choices about which foods they should purchase.
It’s time to stock up on maraschino cherries—Red Dye No. 3 is officially off the market (sorry, Peter Barton Hutt, cherry enthusiast and leading food and drug lawyer). On Jan. 15, 2025, the U.S. Food and Drug Administration (FDA) banned the use of Red Dye No. 3 in food, drinks, and drugs.
By Jessica Samuels You’ve likely seen BPA-free plastic water bottles and Tupperware in stores and opted to grab those over similar, non-labeled products. You probably didn’t know, however, that those products likely just contain other bisphenols, like BPS or BPAF, instead. Regulating bisphenols, a class of endocrine disrupting chemicals, has been challenging due to “regrettable…
By Jessica Samuels For 100 years, food fortification, the practice of deliberately increasing the content of vitamins and minerals in a food, has been essential to combating public health crises. However, these practices have continued into the modern era. Because overconsumption of nutrients has been linked to toxicity and diseases, public health officials should continue…
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from July 2022.
